Are We Still Friends? What Brexit Means for UK Synthetic Biology
Synthetic biology is one of the big strengths of UK science, but can the country…
Synthetic biology is one of the big strengths of UK science, but can the country…
The rapid spread of Covid-19 around the world has left drug developers with limited time…
The startup Protera is moving from Santiago de Chile to Paris following a €5M Series…
A seed round of €10.1M will fund the launch of the University of Oxford spinout…
UK-based Exscientia has closed a Series C financing round of €54M ($60M) to develop its…
Researchers in Germany and France have combined synthetic biology with microfluidics to create artificial photosynthetic…
The European Commission and global donors have pledged €7.4 billion to a fund aimed at…
The Paris-based BrainVectis, a biotech developing gene therapies for Huntington’s disease and Alzheimer’s disease, has…
Japanese pharma giant Astellas has acquired the UK biotech Nanna Therapeutics for up to €80M…
The UK company MicrofluidX has closed a €1.6M (£1.4 M) seed funding round to develop…
An epigenetics drug developed by the Spanish biopharmaceutical company Oryzon has reduced aggressive behavior in…
The UK company Izana Bioscience is freely providing its phase III-ready anti-inflammatory antibody namilumab in…